Curtis Drug Point Private Limited - Company Profile

It is a pharma private limited company based in Chennai City Corporation, Tamil Nadu, India, established in 2017.
2017 Chennai City Corporation, Tamil Nadu, India Active
Last Updated:
Access Report
About Curtis Drug Point Private Limited

Curtis Drug Point Private Limited, a active private limited company, was established on 18 October 2017 in Chennai City Corporation, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999TN2017PTC119150. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹5.00 Cr.

It upholds a compliant status. Employing 40 professional, Its leadership includes Sundararaj Chandrakumar (Director), Aravindan Selvaraj (Director), Pandurangan Selvaraj (Director). Past directors included Sundararaj Chandrakumar, Aravindan Selvaraj, Selvaraj Manivannan. It holds ₹9.30 Cr open charges and no settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at Tvh Belicia Towers, 7Th Floor, Mrc Nagar 1St Lane, Mrc Nagar, Raja Annamalai Puram, Chennai City Corporation, Tamil Nadu, 600028.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TN2017PTC119150

  • Registration Number

    119150

  • Incorporation Date

    18 October 2017

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹5.00 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 5.00 Cr
  • Company Age 8 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 9.30 Cr
  • Revenue Growth **** -5.05%
  • Profit Growth **** 49.35%
  • Ebitda **** -32.39%
  • Net Worth -33.20%
  • Total Assets -16.15%
Company report

Curtis Drug Point Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Curtis Drug Point Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Curtis Drug Point Private Limited?
Current Directors
Name Designation Appointment Date Status
Sundararaj Chandrakumar Director 31 Oct 2017 Current
Aravindan Selvaraj Director 01 Oct 2018 Current
Pandurangan Selvaraj Director 18 Oct 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 27 Sep 2018 Past
Pramod Abcsdd Additional Director 28 Sep 2019 Past
Pramod Abcsdd Director 01 Oct 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Curtis Drug Point.

Curtis Drug Point Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.05% decrease. The company also saw a substantial improvement in profitability, with a 49.35% increase in profit. The company's net worth observed a substantial decline by a decrease of 33.2%.

Curtis Drug Point revenue growth over time
Curtis Drug Point profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -5.05%
*******
*******
*******
*******
Revenue from Operations
*******
 -5.23%
*******
*******
*******
*******
Total Assets
*******
 -16.15%
*******
*******
*******
*******
Profit or Loss
*******
 49.35%
*******
*******
*******
*******
Net Worth
*******
 -33.20%
*******
*******
*******
*******
EBITDA
*******
 -32.39%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Curtis Drug Point?

In 2023, Curtis Drug Point had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹93,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Sbicap Trustee Company Limited : 9.00 Cr
  • Hdfc Bank Limited : 0.30 Cr
Latest Charge Details
Date Lender Amount Status
21 Feb 2022 Hdfc Bank Limited ₹3.00 M Open
13 Nov 2019 Sbicap Trustee Company Limited ₹9.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Curtis Drug Point?

Curtis Drug Point has a workforce of 40 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Curtis Drug Point, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curtis Drug Point's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Curtis Drug Point
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Curtis Drug Point Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Sbicap Trustee Company Limited of Rs. 9.00 Cr registered on 13 Nov 2019 with Charge ID 100304955 was modified on 13 Jun 2025. was completed.

  • Balance Sheet

    Curtis Drug Point Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100547654 was registered on 21 Feb 2022. was recorded as a recent event.

  • Charges

    A charge with Sbicap Trustee Company Limited amounted to Rs. 9.00 Cr with Charge ID 100304955 was registered on 13 Nov 2019. was recorded as a recent event.

  • Director Appointment

    The activity Aravindan Selvaraj was appointed as a Director was appointed as a Director on 01 Oct 2018 & has been associated with this company since 7 years 4 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Curtis Drug Point Private Limited?

The CIN of Curtis Drug Point Private Limited is U74999TN2017PTC119150.

Where is Curtis Drug Point Private Limited headquartered?

Curtis Drug Point Private Limited is headquartered at Tvh Belicia Towers, 7Th Floor, Mrc Nagar 1St Lane, Mrc Nagar, Raja Annamalai Puram, Chennai City Corporation, Tamil Nadu, 600028.

When was Curtis Drug Point Private Limited incorporated?

Curtis Drug Point Private Limited was incorporated on 18 October 2017.

Who are the current directors of Curtis Drug Point Private Limited?

The current directors of Curtis Drug Point Private Limited are

What is the primary industry of Curtis Drug Point Private Limited?

The primary industry of Curtis Drug Point Private Limited is Trade.

Is Curtis Drug Point Private Limited a listed company?

Curtis Drug Point Private Limited is unlisted.

What is the capital structure of Curtis Drug Point Private Limited?

The authorized capital of Curtis Drug Point Private Limited is ₹5.00 Cr, and the paid-up capital is ₹5.00 Cr.

What is the compliance status of Curtis Drug Point Private Limited?

The compliance status of Curtis Drug Point Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available